Analystreport

Urogen Pharma Ltd (NASDAQ: URGN) was given a new $65.00 price target on by analysts at Ladenburg Thalmann Financial Services. They now have a "buy" rating on the stock.

UroGen Pharma Ltd. - Ordinary Shares  (URGN) 
Last urogen pharma ltd. - ordinary shares earnings: 3/2 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.urogen.com